Bryan Chang

666 total citations
23 papers, 457 citations indexed

About

Bryan Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bryan Chang has authored 23 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Bryan Chang's work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Renal cell carcinoma treatment (5 papers). Bryan Chang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Renal cell carcinoma treatment (5 papers). Bryan Chang collaborates with scholars based in United States, United Kingdom and South Sudan. Bryan Chang's co-authors include Shane Lloyd, Yanhong Deng, Jill Lacy, Stacey Stein, Edward James, Howard S. Höchster, Kimberly L. Johung, Jeremy Kortmansky, Xiangyu Cong and Ronald R. Salem and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Endocrinology.

In The Last Decade

Bryan Chang

23 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Chang United States 9 303 201 115 109 83 23 457
X. Sanz Spain 11 136 0.4× 147 0.7× 168 1.5× 117 1.1× 31 0.4× 32 455
M. R. Green United States 12 414 1.4× 524 2.6× 42 0.4× 35 0.3× 76 0.9× 15 674
Caitlin A. Schonewolf United States 10 72 0.2× 209 1.0× 29 0.3× 74 0.7× 59 0.7× 37 376
A. Cueff France 6 180 0.6× 105 0.5× 70 0.6× 141 1.3× 70 0.8× 10 394
Sara Falivene Italy 9 315 1.0× 137 0.7× 59 0.5× 70 0.6× 58 0.7× 27 521
Malcolm Mason United Kingdom 8 144 0.5× 432 2.1× 76 0.7× 257 2.4× 26 0.3× 14 683
Mario Federico Spain 13 85 0.3× 56 0.3× 29 0.3× 179 1.6× 48 0.6× 29 570
Giovanni Boz Italy 9 218 0.7× 89 0.4× 31 0.3× 134 1.2× 43 0.5× 19 303
Rizvan Mamet United States 6 213 0.7× 240 1.2× 147 1.3× 70 0.6× 6 0.1× 9 433
Richard M. Scher United States 8 287 0.9× 222 1.1× 109 0.9× 107 1.0× 71 0.9× 13 436

Countries citing papers authored by Bryan Chang

Since Specialization
Citations

This map shows the geographic impact of Bryan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Chang more than expected).

Fields of papers citing papers by Bryan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Chang. The network helps show where Bryan Chang may publish in the future.

Co-authorship network of co-authors of Bryan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Chang. A scholar is included among the top collaborators of Bryan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Chang. Bryan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geara, Abdallah Sassine, et al.. (2025). Avacopan for ANCA-associated vasculitis: Beyond the 52-week treatment course. Clinical Nephrology. 104(5). 338–342. 1 indexed citations
2.
Chang, Bryan, et al.. (2025). Comparative Analysis of GnRH Pulse Generator Activity in Intact and Gonadectomized Male and Female Mice. Endocrinology. 166(8). 1 indexed citations
3.
Mancini, B.R., Stacey Stein, Shane Lloyd, et al.. (2018). Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal of Gastrointestinal Oncology. 9(6). 982–988. 6 indexed citations
4.
Stahl, John M., Zenta Walther, Bryan Chang, Howard S. Höchster, & Kimberly L. Johung. (2017). A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease. Cureus. 9(2). e1007–e1007. 3 indexed citations
5.
Stein, Stacey, Edward James, Yanhong Deng, et al.. (2016). Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. British Journal of Cancer. 114(7). 737–743. 153 indexed citations
6.
Stein, Stacey, Xiangyu Cong, Xiaopan Yao, et al.. (2015). Phase II study of Yale modified FOLFIRINOX (mFOLFIRINOX) in locally advanced pancreatic cancer (LAPC).. Journal of Clinical Oncology. 33(15_suppl). e15274–e15274. 1 indexed citations
7.
Chang, Bryan & Muhammad Wasif Saif. (2015). Locally Advanced Pancreatic Adenocarcinoma: Where Are We and Where Are We Going?. JOP, journal of the pancreas. 12(2). 139–143. 1 indexed citations
8.
Wehrenberg-Klee, Eric, et al.. (2014). Development of a HER3 PET probe for breast cancer imaging. 55(10386). 550–550. 7 indexed citations
9.
Johung, Kimberly L., Muhammad Wasif Saif, & Bryan Chang. (2014). Locally Advanced Unresectable Pancreatic Cancer. PubMed. 15(4). 329–31. 2 indexed citations
10.
Chang, Bryan, et al.. (2014). Motion management in gastrointestinal cancers.. PubMed. 5(3). 223–35. 52 indexed citations
11.
Lloyd, Shane & Bryan Chang. (2014). Current strategies in chemoradiation for esophageal cancer.. PubMed. 5(3). 156–65. 40 indexed citations
12.
James, Edward, Xiaopan Yao, Xiangyu Cong, et al.. (2014). Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 32(15_suppl). e15226–e15226. 10 indexed citations
13.
14.
Yao, Xiaopan, Hilary Cain, Bryan Chang, et al.. (2013). The Effect of a Lung Cancer Care Coordination Program on Timeliness of Care. Clinical Lung Cancer. 14(5). 527–534. 56 indexed citations
15.
Lloyd, Shane & Bryan Chang. (2013). A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer.. PubMed. 4(2). 123–30. 13 indexed citations
16.
Saif, Muhammad Wasif, John Ng, Bryan Chang, & Suzanne Russo. (2012). Is There a Role of Radiotherapy in the Management of Pancreatic Neuroendocrine Tumors (PNET)?. PubMed. 13(2). 174–6. 3 indexed citations
17.
Johung, Kimberly L., Muhammad Wasif Saif, & Bryan Chang. (2011). Treatment of Locally Advanced Pancreatic Cancer: The Role of Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 82(2). 508–518. 28 indexed citations
18.
Kim, John J., et al.. (2011). A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy. Practical Radiation Oncology. 1(2). 126–134. 23 indexed citations
19.
Chang, Bryan, et al.. (2010). Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.. PubMed. 11(4). 313–6. 5 indexed citations
20.
Chang, Bryan, David H. Kim, Diane Kowalski, et al.. (2004). Prognostic Significance of Cyclooxygenase-2 in Oropharyngeal Squamous Cell Carcinoma. Clinical Cancer Research. 10(5). 1678–1684. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by X. Sanz Breakdown of academic impact, for papers by M. R. Green Breakdown of academic impact, for papers by Caitlin A. Schonewolf Breakdown of academic impact, for papers by A. Cueff Breakdown of academic impact, for papers by Sara Falivene Breakdown of academic impact, for papers by Malcolm Mason Breakdown of academic impact, for papers by Mario Federico Breakdown of academic impact, for papers by Giovanni Boz Breakdown of academic impact, for papers by Rizvan Mamet Breakdown of academic impact, for papers by Richard M. Scher
Rankless by CCL
2026